论文部分内容阅读
目的探讨奥扎格雷钠联合葛根素注射液对缺血性脑血管疾病患者的治疗效果。方法将120例缺血性脑血管疾病患者随机分为治疗组60例和对照组60例,治疗组采用奥扎格雷钠加葛根素注射液治疗,对照组采用葛根素注射液治疗,疗程均为15 d。结果两组患者疗效间差异有统计学意义(P<0.05)。结论奥扎格雷钠联合葛根素注射液治疗缺血性脑血管疾病效果确切、安全,优于单用葛根素注射液治疗。
Objective To investigate the therapeutic effect of ozagrel combined with puerarin on patients with ischemic cerebrovascular disease. Methods A total of 120 patients with ischemic cerebrovascular disease were randomly divided into treatment group (60 cases) and control group (60 cases). The treatment group was treated with ozagrel sodium and puerarin injection, and the control group was treated with puerarin injection. The course of treatment was 15 d. Results The difference between the two groups was statistically significant (P <0.05). Conclusion Ozagrel sodium combined with puerarin injection for the treatment of ischemic cerebrovascular disease is effective and safe, which is better than puerarin injection alone.